23
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Dark Cell Pathology in Meniere's Disease

, &
Pages 479-485 | Received 02 Apr 1991, Accepted 06 May 1991, Published online: 08 Jul 2009
 

Abstract

The dark cells in the cristae of the semicircular canals were studied histopathologically in 9 temporal bones from individuals with Meniere's disease (MD group), 7 temporal bones with endolymphatic hydrops from individuals without a history of Meniere's disease (non-MD hydrops group), and 10 normal temporal bones (control group). The density of the dark cells was significantly lower in specimens in the MO group versus the non-MD hydrops group (Wilcox-on's ranking test, t=90.5, p<0.0l) and control group (Wilcoxon's ranking test, t=50.0, p<0.01), and many of the dark cells were found to be abnormal in the specimens from the MD group. The difference in dark cell density between the non-MD hydrops group and control group, however, was not significant (Wilcoxon's ranking test, t=75.0), and few cells in these groups were abnormal. It is speculated that the differences in density and the abnormalities in dark cell morphology might be either factors in the etiology of endolymphatic hydrops or results of Meniere's disease. Other, unknown, factors must be postulated to produce endolymphatic hydrops in ears with hydrops but without MD.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.